Holahan Melissa L, Brown Andrew J, Drobatz Kenneth J
Section of Critical Care, Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
J Vet Emerg Crit Care (San Antonio). 2010 Aug;20(4):413-20. doi: 10.1111/j.1476-4431.2010.00551.x.
To determine the association of blood lactate with outcome and response to transfusion therapy in dogs with idiopathic immune-mediated hemolytic anemia (IMHA).
Retrospective study.
Urban veterinary small animal emergency hospital.
One hundred and seventy-three client-owned dogs with IMHA.
None.
Serial blood lactate concentration, therapeutic interventions, and outcome were recorded. Nonsurvivors were defined as those that died or were euthanized. One hundred and thirty-three dogs (77%) survived, 35 (20%) were euthanized, and 5 (3%) died. One hundred forty-five dogs (84%; 145/173) had a lactate concentration above the laboratory reference interval [0.46-2.31 mmol/L] on presentation. Blood lactate at presentation was higher in the nonsurvivors (median 4.8 mmol/L; 0.5-13.6) compared with survivors (median 2.9 mmol/L; 0.3-13.2) (P<0.01). All dogs presenting with hyperlactatemia that normalized (<2.0 mmol/L) within 6 hours of admission survived, whereas, 71% of dogs that had a persistent hyperlactatemia at 6 hours survived (P=0.034). Lactate was positively correlated with age, BUN, and alkaline phosphatase, and inversely correlated with PCV. Receiver operating curve analysis for lactate concentration at admission as a test for outcome had an area under the curve of 0.69 with an optimal lactate cutoff concentration of 4.4 mmol/L correctly predicting outcome 73% of the time (sensitivity 60%, specificity 77%).
Lactate concentration at presentation was significantly higher in nonsurvivors than survivors. Lactate was significantly correlated with previously reported outcome variables but lactate concentration at admission, as a predictor for outcome was less than optimal. However, serial lactate concentration measurements may be more predictive as patients with persistent hyperlactatemia 6 hours after admission were less likely to survive. Prospective studies evaluating serial lactate concentration while controlling for other variables may provide further insight into lactate measurement as a prognostic indicator in animals with IMHA.
确定特发性免疫介导性溶血性贫血(IMHA)犬的血乳酸水平与预后及输血治疗反应之间的关联。
回顾性研究。
城市兽医小动物急诊医院。
173只客户拥有的患有IMHA的犬。
无。
记录系列血乳酸浓度、治疗干预措施及预后情况。非存活者定义为死亡或实施安乐死的犬。133只犬(77%)存活,35只(20%)实施安乐死,5只(3%)死亡。145只犬(84%;145/173)就诊时血乳酸浓度高于实验室参考区间[0.46 - 2.31 mmol/L]。与存活犬(中位数2.9 mmol/L;0.3 - 13.2)相比,非存活犬就诊时的血乳酸水平更高(中位数4.8 mmol/L;0.5 - 13.6)(P<0.01)。所有就诊时高乳酸血症在入院6小时内恢复正常(<2.0 mmol/L)的犬均存活,而6小时时仍存在持续性高乳酸血症的犬中,71%存活(P = 0.034)。乳酸与年龄、血尿素氮和碱性磷酸酶呈正相关,与红细胞压积呈负相关。以入院时乳酸浓度作为预后检测指标的受试者工作特征曲线分析显示,曲线下面积为0.69,最佳乳酸截断浓度为4. mmol/L,能正确预测预后的时间为73%(敏感性60%,特异性77%)。
非存活犬就诊时的乳酸浓度显著高于存活犬。乳酸与先前报道的预后变量显著相关,但入院时的乳酸浓度作为预后预测指标并不理想。然而,系列乳酸浓度测量可能更具预测性,因为入院6小时后仍存在持续性高乳酸血症的患者存活可能性较小。在控制其他变量的同时评估系列乳酸浓度的前瞻性研究可能会进一步深入了解乳酸测量作为IMHA动物预后指标的情况。